MiRNA-451 plays a role as tumor suppressor in human glioma cells

被引:148
作者
Nan, Yang [1 ,2 ,3 ]
Han, Lei [1 ,2 ,3 ]
Zhang, Anling [2 ,3 ]
Wang, Guangxiu [2 ,3 ]
Jia, Zhifan [2 ,3 ]
Yang, Yang [1 ,2 ,3 ]
Yue, Xiao [1 ,2 ,3 ]
Pu, Peiyu [1 ,2 ,3 ]
Zhong, Yue [1 ]
Kang, Chunsheng [1 ,2 ,3 ]
机构
[1] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China
[2] Tianjin Neurol Inst, Lab Neurooncol, Tianjin 300052, Peoples R China
[3] Minist Educ & Tianjin Municipal Govt, Key Lab Neurotrauma Variat & Regenerat, Tianjin, Peoples R China
关键词
Glioma; MicroRNA-451; Akt1; Malignant phenotype; HUMAN GLIOBLASTOMA CELLS; HUMAN CANCERS; MATRIX METALLOPROTEINASES; CYCLIN D1; MICRORNA; EXPRESSION; TARGETS; GROWTH; DIFFERENTIATION; SIGNATURES;
D O I
10.1016/j.brainres.2010.08.074
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression at the post-transcriptional and/or translational level by binding loosely complimentary sequences in the 3'untranslated regions (UTRs) of target mRNAs. Increased expressions of several miRNAs, specifically hsa-miR-21, have been reported to modulate glioma development. Here we report downregulation of miR-451 in A172, LN229 and U251 human glioblastoma cells. Increased expression of miR-451 by administration of miR-451 mimics oligonucleotides reversed the biology of each of the three cell lines, inhibiting cell growth, inducing G0/G1 phase arrest and increasing cell apoptosis. Further, treatment with miR-451 mimics oligonucleotides diminished the invasive capacity of these cells, as the number of cells invading through matrigel was significantly decreased. Akt1, CyclinD1, MMP-2, MMP-9 and Bcl-2 protein expression decreased, and p27 expression increased in a dose-dependent manner with miR-451 mimics oligonucleotides. Taken together, these studies reveal miR-451 impacts glioblastoma cell proliferation, invasion and apoptosis, perhaps via regulation of the PI3K/AKT signaling pathway. We propose an essential role for miR-451 as a tumor-suppressor of human glioma. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 29 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   p27 as a target for cancer therapeutics [J].
Blain, SW ;
Scher, HI ;
Cordon-Cardo, C ;
Koff, A .
CANCER CELL, 2003, 3 (02) :111-115
[3]   PKB binding proteins: Getting in on the akt [J].
Brazil, DP ;
Park, J ;
Hemmings, BA .
CELL, 2002, 111 (03) :293-303
[4]   MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias [J].
Calin, GA ;
Liu, CG ;
Sevignani, C ;
Ferracin, M ;
Felli, N ;
Dumitru, CD ;
Shimizu, M ;
Cimmino, A ;
Zupo, S ;
Dono, M ;
Dell'Aquila, ML ;
Alder, H ;
Rassenti, L ;
Kipps, TJ ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11755-11760
[5]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[6]   Understanding the role of tissue degrading enzymes and their inhibitors in development and disease [J].
Cawston, Tim E. ;
Wilson, Amy J. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (05) :983-1002
[7]   MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033
[8]   MicroRNAs as oncogenes and tumor suppressors [J].
Chen, CZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1768-1771
[9]   The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy [J].
Chu, Isabel M. ;
Hengst, Ludger ;
Slingerland, Joyce M. .
NATURE REVIEWS CANCER, 2008, 8 (04) :253-267
[10]   Extensive modulation of a set of microRNAs in primary glioblastoma [J].
Ciafrè, SA ;
Galardi, S ;
Mangiola, A ;
Ferracin, M ;
Liu, CG ;
Sabatino, G ;
Negrini, M ;
Maira, G ;
Croce, CM ;
Farace, MG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (04) :1351-1358